ScreenerHero

PODD Insulet Corporation - Common Stock

NAS · US · Healthcare · Medical Devices · insulet.com
133.34USD+1.25%Mkt Cap: 9.13B $P/E: 24.61

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising …

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap9.13B USD
Enterprise Value9.55B USD
Revenue (TTM)3.05B USD
Gross Profit1.94B USD
Net Income (TTM)247.10M USD
Revenue/Share43.62 USD
Last Price133.34 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)24.61
P/E (Forward)17.07
PEG1.04
EV/EBITDA15.53
EV/Revenue3.13
P/S2.99
P/B6.42
EPS (TTM)5.34
EPS (Forward)7.72
52W Range
126.503% of range354.88
52W High354.88 USD
52W Low126.50 USD
Profitability
Gross Margin71.63%
Oper. Margin16.18%
EBITDA Margin20.14%
Profit Margin9.12%
ROE16.31%
ROA7.75%
Growth
Revenue Growth23.50%
Earnings Growth328.60%
Cash Flow & Leverage
Operating CF569.30M USD
CapEx (TTM)219.40M USD
FCF Margin7.76%
FCF Yield2.59%
Net Debt413.50M USD
Net Debt/EBITDA0.67
Balance Sheet
Debt/Equity0.63
Current Ratio2.48
Quick Ratio1.51
Book Value/Sh20.51 USD
Cash/Share7.71 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)171.91 USD
Upside (mean)+28.9%
Target Range144.00 USD – 275.00 USD
144.00+28.9% to mean275.00
# Analysts22
Ownership
Shares Out.69.35M
Float69.06M
Insiders0.33%
Institutions106.99%
Short Interest
Short Ratio2.9d
Short % Float8.27%
Short % Out.7.33%
Shares Short5.08M
Short (prev mo.)3.70M
Technical
SMA 50145.24 (-8.2%)
SMA 200193.38 (-31.0%)
Beta1.08
S&P 52W Chg14.58%
Avg Vol (30d)1.53M
Avg Vol (10d)1.64M
Technical Indicators
RSI (14)37.4
MACD-4.4575
MACD Signal-4.1632
MACD Hist.-0.2943
BB Upper150.90 USD
BB Middle138.36 USD
BB Lower125.81 USD
BB Width18.13%
ATR (14)5.031 USD
Vol Ratio (20d)1.88x